Campaigns are coming soon. We are putting the final touches in place — check back shortly to start or support a campaign.

Hairraiser
← All guides
Treatments

Finasteride vs minoxidil: the evidence, honestly

12 min readUpdated Aug 2026Sourced from the NHS and the peer-reviewed literature

Two different jobs

Finasteride and minoxidil are the two medicines with the most evidence behind them for male pattern hair loss, and they are in fact the only two FDA-approved drugs for it. But they do different things, and understanding the difference is the whole game. The NHS names finasteride and minoxidil as the main treatments for male pattern baldness, adding they do not work for everyone and only work for as long as they are used. The FDA approved both for this condition as of 2017.

Finasteride works on the hormonal cause. It blocks 5-alpha-reductase, lowering scalp and blood DHT, so it slows or stops the follicle miniaturisation that causes pattern loss. Its job is defence.
Minoxidil (often under the trade name Rogaine) works on the growth side. It is a topical applied to the scalp that extends the hair's growth phase and stimulates the follicle. Its job is growth.

Finasteride: the evidence

Finasteride (1 mg a day, by prescription) is the DHT blocker. The FDA prescribing information states it lowers DHT and has been shown to slow progression and increase hair count in some men with mild-to-moderate pattern hair loss. The evidence shows it is most decisively effective at preserving the hair you have and slowing further loss. Regrowth is more modest and less predictable than marketing claims suggest: two meta-analyses report roughly 15% hair regrowth, and oral finasteride was observed to regrow about 18 hairs per square centimetre (a full head has roughly 120 hairs per square centimetre). It does not re-grow a receded hairline for most men; it protects what remains. It is most effective on the crown, though it can slow loss across the scalp.

It must be taken daily and consistently. Results take 3 to 6 months to appear, and the benefit depends on continued use.
Stopping reverses the effect. The NHS notes these treatments only work for as long as they are used.
Not all men respond. The NHS: they do not work for everyone.
It is for the crown and mid-scalp, not primarily the hairline, in most evidence.

Finasteride side effects: the honest numbers

This is the part people are rightly most anxious about, and it deserves straight talk. Sex-related side effects (reduced libido, erectile dysfunction, decreased ejaculate volume) are the most common adverse effects reported for finasteride taken for hair loss. The honest bottom line: side effects are real for a minority, most reported sexual effects are reversible, but a smaller fraction persist, which is exactly why this is a prescription drug to be taken under medical supervision, not a self-selected pill.

A 2010 Cochrane review (weighted mean age 62, finasteride for BPH) found men taking it are at increased risk of impotence, erectile dysfunction, decreased libido, and ejaculation disorder versus placebo. Rates became indistinguishable from placebo after 2 to 4 years.
A 2017 retrospective study of nearly 12,000 patients found roughly 1.4% developed persistent erectile dysfunction (lasting 90 days or more after stopping finasteride). Among 16 to 42-year-olds it was roughly 0.8%.
Some men report sexual and mood effects that persist after stopping, a debated post-finasteride syndrome. A 2019 BMJ editorial called it ill defined and controversial, and a 2023 systematic review found full reversibility in some studies but persistent symptoms in others.
Gynecomastia (breast tissue) risk is low, roughly 1.5% with the 5-alpha-reductase inhibitor class. A 2018 meta-analysis found no higher risk of breast cancer.
In 2025 the European Medicines Agency confirmed that suicidal thoughts can occur as a side effect of finasteride (the 1 mg hair-loss dose), though its frequency could not be determined from available data.

Minoxidil: foam, liquid, and the oral question

Minoxidil is applied topically at 5% strength (the standard men's dose; 2% is also sold). It is the growth lever: it prolongs the hair's growth (anagen) phase. Effects take patience: 3 to 6 or more months for visible change, judged at around a year. A shedding phase in the first weeks to months is normal, as old resting hairs are pushed out by new growth. It is not a sign the product is failing. It is available over the counter; brand (Rogaine) and generics work the same.

Consistency is everything. Twice-daily application, roughly 12 hours apart, is the protocol shown in trials; a once-a-day habit is less proven.
Stop and the growth is lost. The NHS: these drugs only work for as long as they are used.
It works best on the crown and mid-scalp, with weaker, more variable effect on the hairline, a similar caveat to finasteride.
Irritation or itching at the application site can occur (the foam formulation tends to irritate less than the liquid).
Oral minoxidil (a low-dose tablet) has grown popular but is prescription-only and off-label. It carries more systemic risk, including blood pressure effects and fluid retention, and should only follow a doctor's assessment.

Why consistency beats everything

The single most common reason medical treatment appears not to work is that people stop before the evidence could possibly show. Both of these drugs are judged on a months-to-a-year timescale, yet a large share of men abandon them after a few weeks when they see no change or startle at the normal initial shedding.

Set a 6-month checkpoint, not a 3-week one, before judging anything.
Log a photo from the same angle and lighting at baseline so no change is measured, not felt.
Pair finasteride (defence) with minoxidil (growth) and give the combination the full check-in window.
Revisit with your doctor at the checkpoint; re-evaluate, do not just grit through.

Where surgery and meds meet

Medication and a hair transplant are not rivals; they are partners. A transplant moves hair; it does nothing to stop future loss. Meds protect the donor supply by slowing the ongoing loss that a transplant alone cannot address. Meds, where appropriate, can stabilise a pattern before you invest in surgery, so the plan you fund is based on a steadier baseline.

Meds protect the donor supply by slowing the ongoing loss that a transplant alone cannot address.
Meds can stabilise a pattern before you invest in surgery, so the plan you fund is based on a steadier baseline.
Meds are an ongoing line item whereas a transplant is typically a one-time event. Many men choose to keep meds after a transplant to protect the untouched hair around it.

The bottom line

Finasteride and minoxidil are the two best-evidenced medical options, in fact the two FDA-approved drugs for male pattern hair loss, and they work on complementary levers: finasteride protects, minoxidil grows. Both demand patience (3 to 6 months to notice, roughly 12 months to judge) and complete consistency, and both reverse if you stop. The NHS states they only work for as long as they are used. Side effects are real for a minority and must be weighed with a doctor: most reported sexual effects reverse, but a smaller, debated fraction persist, and the EMA in 2025 flagged a possible psychiatric side-effect signal. Every number here traces to a source that was opened.

Ready to take the next step?

Start a campaign with a real quote from a real clinic — the community funds the rest.

Start a campaign

Educational content only — not medical advice. Costs vary by market and case; get quotes in writing.